(Q37777538)

23 August 2017

1 reference

title

HER2 fragmentation and breast cancer stratification (English)

1 reference

23 August 2017

HER2 Fragmentation and Breast Cancer Stratification (English)

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-1501

16 June 2024

1

Joaquín Arribas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682714

16 June 2024

author name string

Josep Lluís Parra-Palau

2

1 reference

23 August 2017

Kim Pedersen

3

1 reference

23 August 2017

language of work or name

English

0 references

publication date

3 August 2010

1 reference

full work available at URL

23 August 2017

http://clincancerres.aacrjournals.org/content/16/16/4071.full.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682714

http://clincancerres.aacrjournals.org/cgi/content/abstract/16/16/4071

16 June 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20682714

https://aacrjournals.org/clincancerres/article-pdf/16/16/4071/1991641/4071.pdf

16 June 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-1501

16 June 2024

published in

Clinical Cancer Research

1 reference

23 August 2017

volume

16

1 reference

23 August 2017

issue

16

1 reference

23 August 2017

page(s)

4071-4073

1 reference

Quantitation of p95HER2 in Paraffin Sections by Using a p95-Specific Antibody and Correlation with Outcome in a Cohort of Trastuzumab-Treated Breast Cancer Patients

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-1501

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

16 June 2024

2

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-1501

p95HER-2 predicts worse outcome in patients with HER-2-positive breast cancer

16 June 2024

3

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-1501

Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer.

16 June 2024

4

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-1501

Clinical benefit of lapatinib-based therapy in patients with human epidermal growth factor receptor 2-positive breast tumors coexpressing the truncated p95HER2 receptor.

16 June 2024

5

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-1501

Selective inhibition of ADAM metalloproteases blocks HER-2 extracellular domain (ECD) cleavage and potentiates the anti-tumor effects of trastuzumab

16 June 2024

6

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-1501

Truncated ErbB2 receptor (p95ErbB2) is regulated by heregulin through heterodimer formation with ErbB3 yet remains sensitive to the dual EGFR/ErbB2 kinase inhibitor GW572016.

16 June 2024

7

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-1501

Purification of Her-2 extracellular domain and identification of its cleavage site

16 June 2024

8

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-1501

A naturally occurring HER2 carboxy-terminal fragment promotes mammary tumor growth and metastasis

16 June 2024

9

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-1501

Biosynthesis of tumorigenic HER2 C-terminal fragments by alternative initiation of translation.

16 June 2024

10

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-1501

Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab

16 June 2024

11

1 reference

https://api.crossref.org/works/10.1158/1078-0432.CCR-10-1501

16 June 2024

Identifiers

1 reference

23 August 2017

1 reference